Literature DB >> 18435684

Risk factors for Enterobacteriaceae bacteremia after liver transplantation.

Claire Bellier1, Frédéric Bert, François Durand, Sylvie Retout, Jacques Belghiti, France Mentré, Bruno Fantin.   

Abstract

Enterobacteriaceae are now the predominant pathogens isolated in bloodstream infections complicating orthotopic liver transplantation (OLT). We conducted a retrospective cohort study of patients who underwent OLT in a University hospital between 01/01/1997 and 31/03/2003 to investigate the risk factors of Enterobacteriaceae bacteremia (EB) after OLT. EB was defined as the isolation of an Enterobacteriaceae species from at least one blood culture within 3 months following OLT. Pre-, per- and postoperative variables were collected from the medical records and analyzed in relation to EB. Forty (12.5%) of the 320 patients developed EB. The origin of EB was abdominal in 32% of the patients, urinary in 18%, pulmonary in 10%, and primary in the remaining 40% of the patients. Two-thirds of EB occurred within 1 month following OLT. The main pathogens were Escherichia coli (42%), Enterobacter cloacae (17%) and Klebsiella pneumoniae (17%). Susceptibility rates varied from 82.5% for ciprofloxacin to 95% for amikacin. Fourteen patients (35%) with EB died. Variables significantly associated with EB after multivariate analysis were a MELD score >20 (OR: 2.79 [1.24-6.30], P=0.013), transplantation for posthepatitic B (OR: 4.47 [1.67-11.98], P=0.03) or posthepatitic C (OR: 3.79 [1.59-9.01], P=0.03) cirrhosis, a positive bile culture (OR: 3.47 [1.19-10.13], P=0.023) and return to surgery (including retransplantation) (OR: 2.72 [1.32-5.58], P=0.006). EB is a frequent and severe complication following OLT. Patients grafted for a posthepatitic cirrhosis, with a severe pretransplantation status, with a positive bile culture and those undergoing reoperation have a high risk of developing EB.

Entities:  

Mesh:

Year:  2008        PMID: 18435684     DOI: 10.1111/j.1432-2277.2008.00673.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

1.  Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.

Authors:  Maristela Pinheiro Freire; Isabel C V S Oshiro; Ligia C Pierrotti; Patricia R Bonazzi; Larissa M de Oliveira; Alice T W Song; Carlos H Camargo; Inneke M van der Heijden; Flavia Rossi; Silvia F Costa; Luiz A C DʼAlbuquerque; Edson Abdala
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Living donor liver transplantation for end-stage liver disease with severe hepatopulmonary syndrome: report of a case.

Authors:  Takashi Motomura; Toru Ikegami; Yohei Mano; Shigeyuki Nagata; Keishi Sugimachi; Tomoharu Gion; Yuji Soejima; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

3.  Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma.

Authors:  Kai Nie; Rongzheng Ran; Weifeng Tan; Bin Yi; Xiangji Luo; Yong Yu; Xiaoqing Jiang
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

Review 4.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Analysis of infections in the first 3-month after living donor liver transplantation.

Authors:  Chuan Li; Tian-Fu Wen; Kai Mi; Chuan Wang; Lu-Nan Yan; Bo Li
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

6.  Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.

Authors:  A J Mathers; H L Cox; H Bonatti; B Kitchel; A K C Brassinga; B Wispelwey; R G Sawyer; T L Pruett; K C Hazen; J B Patel; C D Sifri
Journal:  Transpl Infect Dis       Date:  2009-02-18       Impact factor: 2.228

7.  Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France.

Authors:  Frédéric Bert; Béatrice Larroque; Catherine Paugam-Burtz; Federica Dondero; François Durand; Estelle Marcon; Jacques Belghiti; Richard Moreau; Marie-Hélène Nicolas-Chanoine
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

8.  Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients.

Authors:  Carlos A Q Santos; Richard S Hotchkiss; William C Chapman; Margaret A Olsen
Journal:  Transplant Direct       Date:  2016-02-22

9.  Poor outcomes of early recurrent post-transplant bloodstream infection in living-donor liver transplant recipients.

Authors:  Si-Ho Kim; Seok Jun Mun; Jae-Hoon Ko; Kyungmin Huh; Sun Young Cho; Cheol-In Kang; Doo Ryeon Chung; Gyu-Seong Choi; Jong Man Kim; Jae-Won Joh; Kyong Ran Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-21       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.